Moritz Maas
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
-
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Tilman Todenhöfer (12 shared papers)Peter C. Black (1 shared paper)Arnulf Stenzl (18 shared papers)Jens Bedke (11 shared papers)Simon Walz (12 shared papers)Steffen Rausch (9 shared papers)Viktoria Stühler (6 shared papers)Jörg Hennenlotter (7 shared papers)
In The Last Decade
Moritz Maas
23 papers receiving 321 citations
Moritz Maas's Hit Papers
Peers
Comparison fields: 5 of 49
- Oncology 101
- Cancer Research 41
- Surgery 112
- Pulmonary and Respiratory Medicine 57
- Urology 10
Countries citing papers authored by Moritz Maas
This map shows the geographic impact of Moritz Maas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moritz Maas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moritz Maas more than expected).
Fields of papers citing papers by Moritz Maas
This network shows the impact of papers produced by Moritz Maas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moritz Maas. The network helps show where Moritz Maas may publish in the future.
Co-authors
The 25 scholars most cited alongside Moritz Maas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Urine biomarkers in bladder cancer — current status and future perspectives Hit paper breakdown → | 2023 | 84 |
| 2 | 2018 | 47 | |
| 3 | 2018 | 28 | |
| 4 | 2018 | 21 | |
| 5 | 2020 | 19 | |
| 6 | 2023 | 16 | |
| 7 | 2019 | 16 | |
| 8 | 2022 | 13 | |
| 9 | 2018 | 13 | |
| 10 | 2018 | 11 | |
| 11 | 2017 | 8 | |
| 12 | 2018 | 8 | |
| 13 | 2021 | 7 | |
| 14 | 2019 | 6 | |
| 15 | 2024 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2016 | 4 | |
| 18 | 2021 | 3 | |
| 19 | 2020 | 3 | |
| 20 | 2023 | 2 |
About Moritz Maas
Moritz Maas is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology, having authored 23 papers that have together received 322 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (10 papers), Urinary and Genital Oncology Studies (4 papers), Prostate Cancer Treatment and Research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Cells and Metastasis (3 papers), Renal cell carcinoma treatment (2 papers), Bone health and treatments (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Oncology (101 citations), Cancer Research (41 citations), Surgery (112 citations), Pulmonary and Respiratory Medicine (57 citations) and Urology (10 citations). Moritz Maas has collaborated with scholars based in Germany, Austria and Canada. Frequent co-authors include Tilman Todenhöfer, Peter C. Black, Arnulf Stenzl, Jens Bedke, Simon Walz, Steffen Rausch, Viktoria Stühler, Jörg Hennenlotter, Miriam Hegemann and Arend G. J. Aalbers. Their work appears in journals such as World Journal of Urology, Disease Markers, Asian Journal of Andrology, Expert Opinion on Biological Therapy and British Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.